KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nektar Therapeutics (NKTR) Retained Earnings: 2010-2024

Historic Retained Earnings for Nektar Therapeutics (NKTR) over the last 15 years, with Dec 2024 value amounting to -$3.6 billion.

  • Nektar Therapeutics' Retained Earnings fell 3.35% to -$3.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.7 billion, marking a year-over-year decrease of 3.35%. This contributed to the annual value of -$3.6 billion for FY2024, which is 3.42% down from last year.
  • According to the latest figures from FY2024, Nektar Therapeutics' Retained Earnings is -$3.6 billion, which was down 3.42% from -$3.5 billion recorded in FY2023.
  • Nektar Therapeutics' Retained Earnings' 5-year high stood at -$2.3 billion during FY2020, with a 5-year trough of -$3.6 billion in FY2024.
  • Over the past 3 years, Nektar Therapeutics' median Retained Earnings value was -$3.5 billion (recorded in 2023), while the average stood at -$3.4 billion.
  • Data for Nektar Therapeutics' Retained Earnings shows a maximum YoY dropped of 23.83% (in 2020) over the last 5 years.
  • Over the past 5 years, Nektar Therapeutics' Retained Earnings (Yearly) stood at -$2.3 billion in 2020, then dropped by 22.69% to -$2.8 billion in 2021, then dropped by 13.00% to -$3.2 billion in 2022, then declined by 8.62% to -$3.5 billion in 2023, then fell by 3.42% to -$3.6 billion in 2024.